New eye drug trial offers hope for rare vision condition
NCT ID NCT06709339
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a drug called faricimab, given as an eye injection, for Caucasian patients with polypoidal choroidal vasculopathy (PCV), a condition that causes vision loss. About 120 participants will receive the treatment and be monitored for up to 48 weeks to see if their eyesight improves and how long the effects last. The goal is to find a safe and effective way to manage this eye disease.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POLYPOIDAL CHOROIDAL VASCULOPATHY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
ASST-Fatebenefratelli-Sacco P.O.L. Sacco
NOT_YET_RECRUITINGMilan, Italy
-
Centro de Oftalmologia Barraquer
RECRUITINGBarcelona, Spain
-
Clinical Eye Research Centre - St. Paul's Eye Unit, Royal Liverpool University Hospital
RECRUITINGLiverpool, United Kingdom
-
Clinical Trial Unit, Dep. Ophth., Gloucestershire Hospitals NHS Foundation Trust
RECRUITINGLondon, United Kingdom
-
Clinical Trial Unit, Dep. Ophth., Gloucestershire Hospitals NHS Foundation Trust,
RECRUITINGGloucester, United Kingdom
-
Department of Ophthalmology, Fundación Jiménez Díaz University Hospital
NOT_YET_RECRUITINGMadrid, Spain
-
Department of Ophthalmology, Porto Medical School / Hospital S. João
NOT_YET_RECRUITINGPorto, Portugal
-
Department of Ophthalmology, University Vita Salute - Scientific Institute of San Raffaele
NOT_YET_RECRUITINGSan Raffaele, Italy
-
Department of Ophthalmology, University of Udine
NOT_YET_RECRUITINGUdine, Italy
-
Espaço Médico de Coimbra
RECRUITINGCoimbra, Portugal
-
Eye Unit, University Hospital Maggiore della Carità
NOT_YET_RECRUITINGNovara, Italy
-
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico-Clinica Regina Elena
NOT_YET_RECRUITINGMilan, Italy
-
Fundación de Oftalmología Médica de la Comunitat Valenciana (Fom)
NOT_YET_RECRUITINGValencia, Spain
-
Hospital Vall d'Hebrón Department of Ophthalmology
NOT_YET_RECRUITINGBarcelona, Spain
-
ICORG - Imperial College Ophthalmologic Research Group
NOT_YET_RECRUITINGLondon, United Kingdom
-
IRCCS Fondazione G.B. Bietti per lo Studio e la Ricerca in Oftalmologia ONLUS,
RECRUITINGRoma, Italy
-
Institut Català de Retina (ICR), Clinical Trial Unit
RECRUITINGBarcelona, Spain
-
Instituto Oftalmologico Fernandez-Veja
NOT_YET_RECRUITINGOviedo, Spain
-
Instituto Oftalmologico Fernandez-Veja
NOT_YET_RECRUITINGOviedo, Spain
-
Instituto de Retina e Diabetes Ocular de Lisboa (IRL),
RECRUITINGLisbon, Portugal
-
Medical Retina Service, Operative Unit Ophthalmology - MultiMedica Spa (IRCCSMM)
NOT_YET_RECRUITINGMilan, Italy
-
Ophthalmology Department, Hospitais Universidade de Coimbra,
RECRUITINGCoimbra, Portugal
-
Serviço Oftalmologia, Centro Hospitalar Universitário de Santo António, E.P.E.,
RECRUITINGPorto, Portugal
-
Serviço de Oftalmologia, Centro Hospitalar Lisboa Norte, Hospital de Santa Maria
RECRUITINGLisbon, Portugal
-
ULS-LOD - Hospital Beatriz Ângelo
RECRUITINGLoures, Portugal
-
Unidade Local de Saúde São José
RECRUITINGLisbon, Portugal
-
Unidade Local de Saúde da Região de Leiria, E.P.E.
RECRUITINGLeiria, Portugal
-
University Hospital Southampton NHS Foundation Trust
RECRUITINGSouthampton, United Kingdom
-
Valles Ophthalmology Research, S.L., Hospital General de Catalunya,
NOT_YET_RECRUITINGBarcelona, Spain
-
Wolverhampton and Midland Counties Eye Infirmary, New Cross Hospital
NOT_YET_RECRUITINGWolverhampton, United Kingdom
-
almPRIMUM- Serviços de Oftalmologia Médica e Cirúrgica
RECRUITINGLisbon, Portugal
More trials for these conditions
Other studies related to the condition(s) this trial covers.